Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR

by Wang Fen, Wang Shuhang, Wang Zhijie, Duan Jianchun, An Tongtong, Zhao Jun, Bai Hua, Wang Jie
Published 2012-08-01

DNA Methylation status of Wnt antagonist <it>SFRP5</it> can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer

by Zhu Jian, Wang Yuyan, Duan Jianchun, Bai Hua, Wang Zhijie, Wei Lai, Zhao Jun, Zhuo Minglei, Wang Shuhang, Yang Lu, An Tongtong, Wu Meina, Wang Jie
Published 2012-09-01